Dose-Escalation Safety and Pharmacokinetic Study of K305
NCT01304316
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Anesthesia
Interventions
DRUG:
Tetracaine HCl 3% and Oxymetazoline HCl 0.05%
Sponsor
St. Renatus, LLC
Collaborators
[object Object]
[object Object]